查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
HIV 臨床試驗市場規模、份額和趨勢分析報告：按階段（I~IV期）、研究設計（干預、擴大訪問）、贊助商、地區市場預測2022-2030
市場調查報告書
商品編碼
1114045

HIV 臨床試驗市場規模、份額和趨勢分析報告：按階段（I~IV期）、研究設計（干預、擴大訪問）、贊助商、地區市場預測2022-2030

HIV Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Expanded Access), By Sponsor, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 98 Pages | 商品交期: 2-10個工作天內

價格

HIV 臨床試驗市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，到 2030 年，全球 HIV 臨床試驗市場預計將達到 21 億美元。從 2022 年到 2030 年，預計將以 6.3% 的複合年增長率增長。由於 HIV 疫苗臨床試驗數量的增加、HIV 臨床試驗的研發活動增加以及對 HIV 感染的認識不斷提高，該市場的主要驅動力是參與臨床試驗的患者人數不斷增加。在 COVID-19 大流行期間，市場增長停止。

艾滋病毒/艾滋病臨床試驗的下降是由於政府為預防 COVID-19 而採取的居家令導致臨床試驗被取消和延遲。它還包括對患者招募的干擾，進行臨床試驗的障礙，以及快速研究開發疫苗和醫療產品以預防 COVID-19，這對 HIV 臨床試驗研究產生不利影響。然而，臨床試驗場所、監管機構和政府機構採取的戰略措施已顯著減輕了這些影響。

根據世界衛生組織的數據，2020 年將有大約 3770 萬艾滋病毒感染者。觀察到生物技術和製藥公司增加資金和合作夥伴關係可以減少這一數字。此外，政府正在加大力度尋找治療方法並傳播對該疾病的認識。例如，2021 年 10 月，三星 BioLogics 與 Enzolytics Inc. 合作。該合作夥伴關係旨在生產抗 HIV 和抗 SARS-CoV-2 單克隆抗體療法。

然而，對 HIV 臨床研究試驗和預防性治療缺乏認識是阻礙該市場增長的一個因素。根據 BioMed Central Ltd. Europe 的報告，467 名參與者中約有三分之一不知道自己感染了 HIV。結果，對這種疾病的無知和無知阻礙了參與艾滋病毒臨床試驗。

HIV 臨床試驗市場報告亮點

按階段劃分，2021 年第一階段業務收入佔比最大，超過 30.0%。在此部分訪問藥物安全性、耐受性和藥代動力學

根據研究設計，擴展訪問試驗部分預計在預測期內以 6.4% 的最快複合年增長率增長。這是由於該領域不斷增長的技術創新。

2021 年，北美以超過 45.0% 的收入份額在市場上佔據主導地位。這是由於多種艾滋病毒株感染了該地區的多個公民。這就是為什麼有幾家公司正在投資開發疫苗以預防艾滋病毒

內容

第1章調查方法及範圍

  • 市場細分和範圍
    • 產品
    • 營養素
    • 區域範圍
    • 估計/預測時間表
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • Gvr 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析（模型 1）
    • 量價分析（模型 2）
  • 輔助信息列表
  • 主要信息列表
  • 縮寫列表
  • 目的
    • 目的一：
    • 目的二：
    • 目的 3：
    • 目的 4：

第 2 章執行摘要

  • 市場概況

第 3 章 HIV 臨床試驗市場：變量、趨勢和範圍

  • 市場細分和範圍
  • 市場變量分析
    • 市場驅動因素分析
      • 增加藥物批准和新產品發布
      • 增加生物技術和製藥公司的研發計劃
      • 艾滋病毒的發病率增加
    • 市場約束分析
      • 缺乏對 HIV 感染的認識和獲得治療的機會
      • 嚴格的規定
  • 繪製滲透率和增長前景
  • HIV 臨床試驗市場：分析工具
    • PESTEL 分析
    • 波特五力分析
  • COVID-19 對 HIV 臨床試驗市場的影響

第 4 章 HIV 臨床試驗市場：階段細分分析

  • HIV 臨床試驗：2021 年和 2030 年的市場份額分析
  • 第一階段
    • 一期市場，2018-2030
  • 第二階段
    • 2018-2030 年二期市場
  • 第三階段
    • 2018-2030 年第三階段市場
  • 第四階段
    • 第四階段市場，2018-2030

第 5 章 HIV 臨床試驗市場：研究設計細分分析

  • HIV 臨床試驗：2021 年和 2030 年的市場份額分析
  • 干預研究
    • 2018-2030 年干預研究市場
  • 觀察性研究
    • 2018-2030 年觀察性研究市場
  • 擴展訪問調查
    • 2018-2030 年訪問研究市場擴張

第 6 章 HIV 臨床試驗市場：贊助商細分分析

  • HIV 臨床試驗：2021 年和 2030 年的市場份額分析
  • 製藥和生物製藥公司
    • 2018-2030 年製藥和生物製藥市場
  • 非營利組織
    • 2018-2030 年非營利市場
  • 其他
    • 2018-2030 年其他市場

第 7 章。HIV 臨床試驗市場：區域分析

  • HIV 臨床試驗：2021 年和 2030 年的市場份額分析
  • 北美
    • 2018-2030 年北美 HIV 臨床試驗市場
    • 美國
      • 2018-2030 年美國 HIV 臨床試驗市場
    • 加拿大
      • 2018-2030 年加拿大 HIV 臨床試驗市場
  • 歐洲
    • 2018-2030 年歐洲 HIV 臨床試驗市場
    • 英國
      • 2018-2030 年英國 HIV 臨床試驗市場
    • 德國
      • 2018-2030 年德國 HIV 臨床試驗市場
    • 法國
      • 2018-2030 年法國 HIV 臨床試驗市場
    • 意大利
      • 2018-2030 年意大利 HIV 臨床試驗市場
    • 西班牙
      • 2018-2030 年西班牙 HIV 臨床試驗市場
  • 亞太地區
    • 2018-2030 年亞太地區 HIV 臨床試驗市場
    • 日本
      • 2018-2030 年日本 HIV 臨床試驗市場
    • 中國
      • 2018-2030 年中國 HIV 臨床試驗市場
    • 印度
      • 2018-2030 年印度 HIV 臨床試驗市場
    • 泰國
      • 2018-2030 年泰國 HIV 臨床試驗市場
    • 韓國
      • 2018-2030 年韓國 HIV 臨床試驗市場
  • 拉丁美洲
    • 2018-2030 年拉丁美洲 HIV 臨床試驗市場
    • 巴西
      • 2018-2030 年巴西 HIV 臨床試驗市場
    • 墨西哥
      • 2018-2030 年墨西哥 HIV 臨床試驗市場
    • 阿根廷
      • 2018-2030 年阿根廷 HIV 臨床試驗市場
    • 哥倫比亞
      • 2018-2030 年哥倫比亞的 HIV 臨床試驗市場
  • 多邊環境協定
    • 2018-2030 年 MEA HIV 臨床試驗市場
    • 南非
      • 2018-2030 年南非 HIV 臨床試驗市場
    • 沙特阿拉伯
      • 2018-2030 年沙特阿拉伯 HIV 臨床試驗市場
    • 阿拉伯聯合酋長國
      • 2018-2030 年阿拉伯聯合酋長國 HIV 臨床試驗市場

第 8 章公司簡介

  • 公司簡介
    • PPD有限公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Icuvia Inc.
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Parexel 國際公司。
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 圖標公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Syneos Health
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 無錫優普科技
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Janssen World Service, LLC
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 吉利德科學公司
      • 公司概況
      • 產品基準
      • 戰略舉措
    • Bionol 控股公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 查爾斯河實驗室
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 葛蘭素史克公司
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
    • SGS SA
      • 公司概況
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-955-8

HIV Clinical Trials Market Growth & Trends:

The global HIV clinical trials market size is expected to reach USD 2.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.3% from 2022 to 2030. The main drivers of this market are increasing HIV vaccine trials, increased R&D activities for HIV clinical trials, and rising HIV infection awareness, which leads to a large number of patients enrolling in clinical trials. During the COVID-19 pandemic, there was a halt in the market growth.

This decrease in HIV and AIDS clinical trials is due to stay-at-home orders by the government to prevent COVID-19 that led to canceled and delayed trials. It also includes disruption in patient recruitment, hurdles in the conduction of clinical trials, and rapid study for the development of vaccines and medical products for the prevention of COVID-19 that lead to detrimental effects in HIV clinical trial studies. However, these impacts were significantly reduced by adopting strategic measures taken by the clinical trial conducting organization, regulatory authorities, and government bodies.

According to the WHO, in 2020, there were around 37.7 million people infected with HIV infection. To reduce this number, increasing funding and partnerships by biotechnology and pharmaceutical firms have been observed. Moreover, increasing initiatives are being taken by the government to find treatment and spread awareness regarding this disease. For instance, in October 2021, Samsung BioLogics collaborated with Enzolytics Inc. This partnership aims to manufacture Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies.

However, a lack of awareness regarding HIV clinical research trials and the availability of treatments for preventing it are factors that are hindering the growth of this market. According to a report by BioMed Central Ltd. in Europe, out of 467 participants, about one-third of them were not aware of the HIV infection. As a result, ignorance and unawareness regarding the disease will prevent admission to an HIV clinical trial.

HIV Clinical Trials Market Report Highlights:

  • Based on phase, the phase I segment held the largest revenue share of over 30.0% in 2021. In this segment, safety, tolerability, and pharmacokinetics of the drug are accessed
  • By study design, the expanded access studies segment is expected to expand at the fastest CAGR of 6.4% over the forecast period. This is due to the rising innovation in this area
  • North America dominated the market with a revenue share of over 45.0% in 2021. This can be attributed to several citizens being infected with multiple strains of HIV in this region. Due to this, multiple companies are investing in vaccine development to prevent HIV

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Nutrients
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1:
    • 1.10.2 Objective - 2:
    • 1.10.3 Objective - 3:
    • 1.10.4 Objective - 4:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 HIV Clinical Trials Market: Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Variable Analysis
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rising Drug Approvals And New Product Launches
      • 3.2.1.2 Increasing R&D Initiatives By Biotechnology & Pharmaceutical Companies
      • 3.2.1.3 Increasing Incidence Of HIV
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Lack of awareness and access to treatment for HIV Infection
      • 3.2.2.2 Stringent regulations
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 HIV Clinical Trials Market: Analysis Tools
    • 3.4.1 Pestel Analysis
    • 3.4.2 Porter's Five Forces Analysis
  • 3.5 COVID- 19 Impact on HIV Clinical Trials Market

Chapter 4 HIV Clinical Trials Market: Phase Segment Analysis

  • 4.1 HIV Clinical Trials: Market Share Analysis, 2021&2030
  • 4.2 Phase I
    • 4.2.1 Phase I market, 2018 - 2030 (USD Million)
  • 4.3 Phase II
    • 4.3.1 Phase II market, 2018 - 2030 (USD Million)
  • 4.4 Phase III
    • 4.4.1 Phase III market, 2018 - 2030 (USD Million)
  • 4.5 Phase IV
    • 4.5.1 Phase IV market, 2018 - 2030 (USD Million)

Chapter 5 HIV Clinical Trials Market: Study Design Segment Analysis

  • 5.1 HIV Clinical Trials: Market Share Analysis, 2021 & 2030
  • 5.2 Interventional studies
    • 5.2.1 Interventional studies market, 2018 - 2030 (USD Million)
  • 5.3 Observational studies
    • 5.3.1 Observational studies market, 2018 - 2030 (USD Million)
  • 5.4 Expanded access studies
    • 5.4.1 Expanded access studies market, 2018 - 2030 (USD Million)

Chapter 6 HIV Clinical Trials Market: Sponsor Segment Analysis

  • 6.1 HIV Clinical Trials: Market Share Analysis, 2021 & 2030
  • 6.2 Pharmaceutical & biopharmaceutical companies
    • 6.2.1 Pharmaceutical & biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • 6.3 Non-Profit Organizations
    • 6.3.1 Non-Profit Organizations market, 2018 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 HIV Clinical Trials Market: Regional Analysis

  • 7.1 HIV Clinical Trials: Market Share Analysis, 2021 & 2030
  • 7.2 North America
    • 7.2.1 North America HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada HIV Clinical Trials market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain HIV Clinical Trials market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.4.5 Thailand
      • 7.4.5.1 Thailand HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea HIV Clinical Trials market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia HIV Clinical Trials market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia HIV Clinical Trials market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE HIV Clinical Trials market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 PPD Inc.
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 IQVIA Inc.
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Parexel International Corporation.
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 ICON plc
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Syneos Health
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 WuXi AppTec
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 Janssen Global Services, LLC
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Gilead Sciences, Inc.
      • 8.1.8.1 Company overview
      • 8.1.8.2 Product benchmarking
      • 8.1.8.4 Strategic initiatives
    • 8.1.9 Bionor Holding AS
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Product benchmarking
      • 8.1.9.4 Strategic initiatives
    • 8.1.10 Charles River Laboratories
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial performance
      • 8.1.10.3 Product benchmarking
      • 8.1.10.4 Strategic initiatives
    • 8.1.11 GSK plc.
      • 8.1.11.1 Company overview
      • 8.1.11.2 Financial performance
      • 8.1.11.3 Product benchmarking
      • 8.1.11.4 Strategic initiatives
    • 8.1.12 SGS SA
      • 8.1.12.1 Company overview
      • 8.1.12.2 Financial performance
      • 8.1.12.3 Product benchmarking
      • 8.1.12.4 Strategic initiatives

List of Tables

  • Table 1 Global HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 2 Global HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 3 Global HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 4 Global HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 5 North America HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 7 North America HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 8 North America HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 9 U.S. HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 10 U.S. HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 11 U.S. HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 12 U.S. HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 13 Canada HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 14 Canada HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 15 Canada HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 16 Canada HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 17 Europe HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 18 Europe HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 19 Europe HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 20 Europe HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 21 U.K. HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 22 U.K. HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 23 U.K. HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 24 U.K. HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 25 Germany HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 26 Germany HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 27 Germany HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 28 Germany HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 29 France HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 30 France HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 31 France HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 32 France HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 33 Italy HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 34 Italy HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 35 Italy HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 36 Italy HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 37 Spain HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 38 Spain HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 39 Spain HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 40 Spain HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 45 Japan HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 46 Japan HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 47 Japan HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 48 Japan HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 49 India HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 50 India HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 51 India HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 52 India HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 53 China HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 54 China HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 55 China HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 56 China HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 57 Thailand HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 58 Thailand HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 59 Thailand HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 60 Thailand HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 61 South Korea HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 62 South Korea HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 63 South Korea HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 64 South Korea HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 65 Latin America HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 67 Latin America HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 68 Latin America HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 69 Mexico HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 70 Mexico HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 71 Mexico HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 72 Mexico HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 73 Brazil HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 74 Brazil HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 75 Brazil HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 76 Brazil HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 77 Argentina HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 78 Argentina HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 79 Argentina HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 80 Argentina HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 81 Colombia HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 82 Colombia HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 83 Colombia HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 84 Colombia HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 85 MEA HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 86 MEA HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 87 MEA HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 88 MEA HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 89 South Africa HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 90 South Africa HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 91 South Africa HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 92 South Africa HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 96 Saudi Arabia HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)
  • Table 97 UAE HIV clinical trials market, by region, 2018 - 2030 (USD Million)
  • Table 98 UAE HIV clinical trials market, by phase, 2018 - 2030 (USD Million)
  • Table 99 UAE HIV clinical trials market, by study design, 2018 - 2030 (USD Million)
  • Table 100 UAE HIV clinical trials market, by sponsor, 2018 - 2030 (USD Million)  

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 HIV Clinical Trials market snapshot (2021)
  • Fig. 11 Market trends and outlook
  • Fig. 12 HIV Clinical Trials market segmentation
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Penetration & growth prospect mapping
  • Fig. 16 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 17 PORTER'S ANALYSIS
  • Fig. 18 HIV Clinical Trials market phase outlook: Segment dashboard
  • Fig. 19 HIV Clinical Trials market: Phase movement analysis
  • Fig. 20 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 21 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 22 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 23 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 24 HIV Clinical Trials market study design outlook: Segment dashboard
  • Fig. 25 HIV Clinical Trials market: Study Design movement analysis
  • Fig. 26 Interventional studies market, 2018 - 2030 (USD Million)
  • Fig. 27 Observational studies market, 2018 - 2030 (USD Million)
  • Fig. 28 Expanded access studies market, 2018 - 2030 (USD Million)
  • Fig. 29 HIV Clinical Trials market sponsor outlook: Segment dashboard
  • Fig. 30 HIV Clinical Trials market: Sponsor movement analysis
  • Fig. 31 Pharmaceutical & biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 32 Non-Profit Organizations market, 2018 - 2030 (USD Million)
  • Fig. 33 Others market, 2018 - 2030 (USD Million)
  • Fig. 34 Regional marketplace: Key takeaways
  • Fig. 35 Regional outlook, 2021&2030
  • Fig. 36 North America market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe market, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany market, 2018 - 2030 (USD Million)
  • Fig. 42 France market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market, 2018 - 2030 (USD Million)
  • Fig. 47 China market, 2018 - 2030 (USD Million)
  • Fig. 48 India market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 55 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 56 MEA market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market, 2018 - 2030 (USD Million)